• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

New Approaches in Radiopharmaceuticals

Thursday, June 06, 2024
Breakout Session
Oncology
31AB
The panel will discuss how the field of radiopharmaceuticals can integrate concepts from personalized medicine, tailoring treatments based on individual disease characteristics. The panel will also explore the optimization of radiopharmaceutical production and supply chains to meet the growing demand for these innovative treatments. Collaboration between stakeholders, ranging from pharmaceutical companies to research institutions, such as academic medical centers, will be a driving force behind future breakthroughs in radiopharmaceutical development and clinical trials. This session will offer attendees a glimpse into the exciting possibilities that lie ahead in this rapidly evolving field of medical science.
Moderator
Karen Tkach Tuzman, PhD
Director of Biopharma Intelligence, Head of Discovery and Preclinical Research
BioCentury
Speakers
Dave Greenwald, PhD
Vice President, Business Development
Deerfield Management
Ken Song, MD
CEO
RayzeBio
Suji Jeong, PhD
Founding Partner
The SJR Group
Jeevan Virk
Radioligand Therapy (RLT) Therapeutic Area Strategy Head
Novartis
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS